Acquisition of secondary structural chromosomal changes in pediatric Ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome

Cancer

Volumn 91, Issue 11, 2001, Pages 2156-2164

  Zielenska, Maria ^a,b   Zhang, Zong Mei ^a,c   Ng, Kwan ^c   Marrano, Paula ^a,c   Bayani, Jane ^a,c   Ramirez, Oswaldo C ^a   Sorensen, Poul ^d   Thorner, Paul ^a,b   Greenberg, Mark ^b   Squire, Jeremy A ^a,c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

^e PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Interphase fluorescence in situ hybridization; Karyotype; Molecular cytogenetics; Small round cell tumor; Translocation

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; CHILD; CHROMOSOME 12; CHROMOSOME 22Q; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION 1; CLINICAL ARTICLE; EWING SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; INFANT; KARYOTYPE; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPING; MALE; PROGNOSIS; SARCOMA, EWING'S; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035371260     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010601)91:11<2156::AID-CNCR1244>3.0.CO;2-I     Document Type: Article

References (22)

1. Young JL Jr., Miller RW. Incidence of malignant tumors in U.S. children. J Pediatr 1975;86:254-8.
2. Turc-Carel C, Aurias A, Mugneret F, Lizard S, Sidaner I, Volk C, et al. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 1988;32:229-38.
3. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-5.
4. Sorensen PH, Liu XF, Delattre O, Rowland JM, Biggs CA, Thomas G, et al. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol 1993;2:147-57.
5. Thorner PS, Squire JA. Molecular genetics in the diagnosis and prognosis of solid pediatric tumors. Pediatr Dev Pathol 1998;1:337-65.
6. Kullendorff CM, Mertens F, Donner M, Wiebe T, Akerman M, Mandahl N. Cytogenetic aberrations in Ewing sarcoma: are secondary changes associated with clinical outcome? Med Pediatr Oncol 1999;32:79-83.
7. Armengol G, Tarkkanen M, Virolainen M, Forus A, Valle J, Bohling T, et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer 1997;75:1403-9.
8. Maurici D, Perez-Atayde A, Grier HE, Baldini N, Serra M, Fletcher JA. Frequency and implications of chromosome 8 and 12 gains in Ewing sarcoma. Cancer Genet Cytogenet 1998;100:106-10.
9. Hattinger CM, Rumpler S, Strehl S, Ambros IM, Zoubek A, Potschger U, et al. Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors. Genes Chromosomes Cancer 1999;24:243-54.
10. Stark B, Mor C, Jeison M, Gobuzov R, Cohen IJ, Goshen Y, et al. Additional chromosome 1q aberrations and der(16)t(1; 16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors. J Neurooncol 1997; 31:3-8.
11. Fagioli F, Cuneo A, Bardi A, Carli MG, Bigoni R, Balsamo R, et al. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies. Cancer Genet Cytogenet 1995;82:116-22.
12. Mitelman F. The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma 1993;11(Suppl 1):11-5.
13. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3.
14. Heim S, Mitelman F. Cancer cytogenetics. New York: Wiley-Liss, Inc., 1995.
15. Dracopoli NC. Current protocols in human genetics. New York: John Wiley and Sons, Inc., 2000.
16. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, van Dekken H. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosomes Cancer 1995;12:241-50.
17. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
18. Mandahl N, Mertens F, Aman P, Rydholm A, Brosjo O, Willen H, et al. Nonrandom secondary chromosomal aberrations in liposarcomas with t(12;16). Int J Oncol 1994;4: 685-8.
19. Pandita A, Zielenska M, Thorner P, Godbout R, Greenberg M, Bayani J, et al. Comparative genomic hybridization microarray analysis and the application of spectral karyotyping in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia 1999;1:262-73.
20. Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C, Armengol G, Bohling T, Ekfors T, et al. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors. Cancer Genet Cytogenet 1999; 114:35-41.
21. Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993;7:1315-23.
22. Fizazi K, Dohollou N, Blay JY, Guerin S, Le Cesne A, Andre F, et al. Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol 1998;16:3736-43.